The First Affiliated Hospital of Nanjing Medical University
The First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China43 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Mindfulness Intervention for Emotional Distress (MIED) in Patients With GERD | Deglutition Disorders, Digestive System Diseases, digestive system disorder, dyskinesia of esophagus, esophageal disorder, gastroesophageal reflux disease | Recruiting | Not applicable | 2026-10-07 | NCT07667894 | |
| Start CPAP Therapy in Obstructive Sleep Apnea Patients After Atrial Fibrillation Ablation | Apnea, Arrhythmias, Cardiac, Dyssomnias, Neurologic Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Signs and Symptoms, Sleep Disorders, Intrinsic, atrial fibrillation, cardiovascular disorder, heart disorder, nervous system disorder, obstructive sleep apnea syndrome, psychiatric disorder, respiratory system disorder, sleep apnea syndrome, sleep-wake disorder | Recruiting | Not applicable | 2026-10-05 | NCT07444372 | |
| A Phase III Study of SHR-A1811 Injection With or Without Pertuzumab in HER2-Positive Recurrent or Metastatic Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 3 | 2026-09-09 | NCT06057610 | |
| Effectiveness of an AI-Enabled Stratified Management System for Premature Coronary Artery Disease | Premature Coronary Heart Disease | Recruiting | Not applicable | 2026-08-18 | NCT07031531 | |
| CD70-Targeted Immuno-PET/CT-Directed Free of Therapy Used for mccRCC Patients With IMDC Favorable or Intermediate Risk | Clear-cell metastatic renal cell carcinoma | Recruiting | Phase 2 | 2026-08-11 | NCT07615348 | |
| Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer | cancer, neoplasm | Active, not recruiting | Phase 3 | 2026-07-07 | NCT04464226 | |
| Fovinaciclib Plus Aromatase Inhibitors and Dual HER2 Blockade in a Response-Adapted Neoadjuvant Strategy for HR-Positive/HER2-Positive Early Breast Cancer | HR+/HER2+ Early Breast Cancer | Recruiting | Phase 2 | 2026-06-01 | NCT07616427 | |
| Differences in Pelvic Floor Motion Level Among Chinese Women and Construction of an Assessment System | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, Male Urogenital Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urinary Incontinence, Urinary Incontinence, Stress, Urination Disorders, Urogenital Diseases, Urological Manifestations, urinary system disorder | Not yet recruiting | Not stated | 2026-05-27 | NCT07608146 | |
| A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With Intermediate or High Risk Early Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 3 | 2026-05-22 | NCT07349069 | |
| Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression Patterns | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Not stated | 2026-05-22 | NCT06551220 | |
| Perioperative Vericiguat in Patients Undergoing Cardiovascular Surgery | Cardio Vascular Disease; Cardiopulmonary Bypass | Not yet recruiting | Not applicable | 2026-05-18 | NCT07594509 | |
| Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes | Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, diabetes mellitus, disease, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Recruiting | Phase 4 | 2026-04-30 | NCT07558863 | |
| Band Versus Ring for Tricuspid Regurgitation | cardiovascular disorder, heart disorder, heart valve disorder, tricuspid valve insufficiency | Enrolling by invitation | Not applicable | 2026-04-17 | NCT04093297 | |
| Clinical Outcomes and Immunotherapy in Lung Cancer With Pulmonary Fibrosis | Fibrosis, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thoracic Neoplasms, disease, interstitial lung disease, lung disorder, lung neoplasm, neoplasm, pulmonary fibrosis, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Not stated | 2026-03-17 | NCT07396467 | |
| A Phase Ib/III Study of Suvemcitug Plus FTD/TPI in Participants With Refractory Metastatic Colorectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Recruiting | Phase 3 | 2026-01-22 | NCT07361003 | |
| Protective Effect of Probacine Against Negative Gut Metabolism and Organ Dysfunction After Cardiovascular Surgery (PANDA IV) | cardiovascular disorder | Enrolling by invitation | Not applicable | 2026-01-06 | NCT04444362 | |
| Whole Body MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Radiographic axSpA and Non-radiographic axSpA | Spondylarthritis, arthritic joint disease, arthropathy, bone disorder, musculoskeletal system disorder, spondylitis, vertebral column disorder | Recruiting | Not stated | 2025-11-17 | NCT07230327 | |
| Nocardia Rubra Cell Wall Skeleton in Combination With Prior Second- or Third-line Regimens for the Treatment of Potentially Hazardous Colorectal Cancer SD Status | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Recruiting | Phase 2 | 2025-08-08 | NCT06356714 | |
| A Clinical Study on the Efficacy and Safety of Paclitaxel Polymeric Micelles and Cisplatin Combined With Cadonilimab as a Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal disorder, esophageal squamous cell carcinoma, neoplasm, squamous cell carcinoma, squamous cell neoplasm | Recruiting | Phase 2 | 2025-08-08 | NCT06356688 | |
| The Efficacy and Safety of HIPEC Combined With PD-1 and SOX Chemotherapy for the Translational Treatment of GC or EGJC With PM | Digestive System Diseases, Digestive System Neoplasms, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, digestive system disorder, digestive system neoplasm, gastric neoplasm, neoplasm, stomach disorder | Active, not recruiting | Phase 2 | 2025-07-16 | NCT06427252 | |
| A Prospective, Single-arm, Phase II Clinical Study of Tislelizumab Combined With Anlotinib and Platinum-based Doublet Perioperative Therapy for Resectable Stage II-IIIB Driver Gene-negative NSCLC | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Not yet recruiting | Phase 2 | 2025-06-29 | NCT06977828 | |
| Optic Nerve Injury in Obstructive Sleep Apnea Patients | Apnea, Dyssomnias, Optic Neuropathy, Ischemic, Respiration Disorders, Sleep Disorders, Intrinsic, cardiovascular disorder, cranial nerve neuropathy, eye disorder, nervous system disorder, obstructive sleep apnea syndrome, optic nerve disorder, respiratory system disorder, sleep apnea syndrome, sleep-wake disorder, vascular disorder | Recruiting | Not applicable | 2025-06-27 | NCT06748703 | |
| Diaphragmatic Function and Respiratory Drive in OSA and COPD | Apnea, Chronic Disease, Disease Attributes, Dyssomnias, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Sleep Disorders, Intrinsic, chronic obstructive pulmonary disease, lung disorder, nervous system disorder, obstructive lung disease, obstructive sleep apnea syndrome, respiratory system disorder, sleep apnea syndrome, sleep-wake disorder | Recruiting | Not stated | 2025-06-25 | NCT07003399 | |
| Precision OSA Therapy Based on Phenotypes and Endotypes | Apnea, Dyssomnias, Respiration Disorders, Sleep Disorders, Intrinsic, nervous system disorder, obstructive sleep apnea syndrome, respiratory system disorder, sleep apnea syndrome, sleep-wake disorder | Not yet recruiting | Not stated | 2025-02-13 | NCT06825923 | |
| Clinical Study on the Effectiveness and Safety of Lenvatinib As Adjuvant Treatment for Patients with High-risk Recurrence of Hepatocellular Carcinoma After Surgery | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Phase 2 | 2025-01-08 | NCT06762782 |